Limited data suggest that, like NR4A1, NR4A2 is also a pro-oncogenic factor in solid tumors, and in colon cancer, NR4A2 overexpression predicts an unfavorable prognosis and chemoresistance [28]. This evidence concerns the gene NR4A2 and malignant colon neoplasm.